Home › Grafix Demonstrates Superior Clinical Outcomes Compared With EpiFix In Real World' Study
 

Keywords :   


Grafix Demonstrates Superior Clinical Outcomes Compared With EpiFix In Real World' Study

2016-05-03 03:28:13| drugdiscoveryonline News Articles

Osiris Therapeutics, Inc., a leading cellular and regenerative medicine company, focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, announces the results of A Retrospective, Single-Center, Non-Randomized, Cross-Sectional Comparative Effectiveness Study Evaluating Surface Area Reduction, Volume Reduction and Closure Rates in Acute and Chronic Wounds Managed with Grafix versus EpiFix

Tags: real world study compared

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
12.05Is social media worth paying for?
12.05Switzer Ranch staying resilient with long-term outlook
12.05BIF announces Seedstock, Commercial Producer award finalists
11.05Weekly Recap: Hempel, Sherwin-Williams Top This Weeks Stories
11.05LG CHI Color Master Factory Is Awarded Patent
11.05AgriWebb raises $7.2m to fuel further innovation in sustainable beef production
11.05YouGov Unveils Americans Skincare Routines
11.05Naples Soap Company Reports Revenue Surge Amidst Tourist Season
More »